Antiviral Effects of Foscarnet and Ganciclovir Therapy on Human Immunodeficiency Virus p24 Antigen in Patients with AIDS and Cytomegalovirus Retinitis

To examine whether the prolonged survival seen in patients treated with foscarnet compared with those treated with ganciclovir was due to a direct effect on human immunodeficiency virus (HIV) replication, HIV p24 antigen was measured. Of 71 receiving foscarnet, 54% were p24 antigen-positive at enrol...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 172; no. 3; pp. 613 - 621
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.09.1995
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To examine whether the prolonged survival seen in patients treated with foscarnet compared with those treated with ganciclovir was due to a direct effect on human immunodeficiency virus (HIV) replication, HIV p24 antigen was measured. Of 71 receiving foscarnet, 54% were p24 antigen-positive at enrollment (vs. 44% of 79 receiving ganciclovir). By immune complex-dissociated (ICD) p24 antigen analysis, 87% and 78%, respectively, were positive. After 1 month of treatment, there was a significant decline in standard (mean decline, 10.1 pg/mL) and ICD (mean, 39.6 pg/mL) p24 antigen in both groups (P = .0001). Mortality was greater in those who were ICD p24 antigen-positive than in those —negative at baseline (P = .03) and in subjects with an increase in ICD p24 antigen than in those with a decline (P = .09). Thus, each drug had a suppressive effect on circulating p24 antigen, which was predictive of improved survival. The inhibitory effect on CMV replication may have a beneficial effect on limiting HIV replication.
Bibliography:Reprints: Dr. Douglas A. Jabs, Johns Hopkins University School of Medicine, 550 Building, Suite 700, Baltimore, MD 21205.
istex:CD6D96EF5CA62D858E7CA30EC838762EEF74769F
Correspondence: Dr. Thomas C. Quinn, Division of Infectious Diseases, Johns Hopkins University, 720 Rutland Ave., Ross 1159, Baltimore, MD 21205-2196.
ark:/67375/HXZ-QX3H44Z1-N
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/172.3.613